Premium
EXACERBATION RISK DOES NOT INCREASE FOLLOWING SWITCH FROM LABA/ICS TO INDACATEROL/GLYCOPYRRONIUM (IND/GLY) IN PATIENTS WITH COPD: THE DACCORD REAL LIFE STUDY
Publication year - 2017
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13207_245
Subject(s) - indacaterol , medicine , exacerbation , copd exacerbation , citation , copd , library science , lung , lung function , computer science , acute exacerbation of chronic obstructive pulmonary disease